Riehl melanosishttps://en.wikipedia.org/wiki/Riehl_melanosis
Riehl melanosis se yon fòm dermatoz kontak ki kòmanse ak prurit, eritem, ak pigmantè ki pwopaje piti piti; apre li rive nan yon sèten limit, li vin estasyonè. Ekspozisyon solèy apre yo fin itilize kèk pafen oswa krèm ka lakòz maladi a.

☆ AI Dermatology — Free Service
Nan rezilta Stiftung Warentest 2022 ki soti nan Almay, satisfaksyon konsomatè yo ak ModelDerm te sèlman yon ti kras pi ba pase ak konsiltasyon telemedsin peye.
      References Riehl Melanosis 32491369 
      NIH
      Riehl melanosis, souvan rekonèt kòm dèrmatoz kontak pigman, se yon kondisyon po ki koze pa alèji, souvan deklanche pa parfen ak lòt sibstans ki jwenn nan pwodui kosmetik. Malgre li klase kòm yon kalite dèrmatit, Riehl melanosis montre chanjman pigmantasyon sou po a, ak sèlman ti siy iritasyon. Li pi komen lakay moun ki gen ton po pi fonse. Dènye rechèch yo te egzamine efikasite tretman lazè mid‑fluence QSNY 1064‑nm pou adrese pigmantasyon pwofon ki asosye ak Riehl melanosis. Yon lòt etid te konbine diferan terapi, ki gen ladan low‑fluence 1064‑nm Q‑switched Nd:YAG lazè, krèm hydroquinone (idrokinòn), ak asid tranexamic (tranekamik) oral, ki te bay amelyorasyon enpòtan pou pifò pasyan yo.
      Riehl melanosis (RM), commonly called pigmented contact dermatitis, is considered an acquired form of allergic contact dermatitis, typically to fragrance and other ingredients of cosmetic products. Although it is considered as a dermatitis, it presents clinically with hyperpigmentation over the face and shows pigment incontinence with minimal eczematous changes on histology. The condition is more commonly seen in dark-skinned people, causing an important psychosocial impact. A recent study showing the higher effectiveness of mid-fluence QSNY 1064-nm laser in targetting the deep pigmentation of RM has also been conducted. Another study used a combination of therapies to include low-fluence, 1064-nm, Q-switched Nd: YAG laser, hydroquinone cream, and oral tranexamic acid, with the majority of patients experiencing significant improvement.
       Research Advances in the Treatment of Riehl’s Melanosis 37168093 
      NIH
      Riehl's melanosis se yon kalite kondisyon po ki koze pa kontak ak sèten alèrjèn ak ekspoze a limyè solèy la. Li mennen nan pigmantasyon rapid, pwogresif gri‑mawon sou po a, ki ka afekte pasyan anpil, tou de mantalman ak fizikman. Pandan ke kòz egzak Riehl's melanosis toujou enkoni, rechèch ki egziste deja endike yon lyen solid ak ekspoze a alèrjèn. Pou trete li, yo te eseye medikaman tradisyonèl ak terapi lazè, souvan ansanm ak itilizasyon ajan klowòks sou po a. Terapi lazè, espesyalman lè l sèvi avèk Q‑switched Nd:YAG lazè, te montre rezilta pwomèt pou trete Riehl's melanosis. Konbine diferan apwòch tretman te mennen rezilta pozitif.
      Riehl's melanosis (RM) is a contact photodermatitis, with fast progressive gray-brown skin pigmentation as the main manifestation, which can seriously affect the psychology and physiology of patients. Currently, although the etiological factors of Riehl's melanosis is still be unknown, the existing literature proves clearly the cause of it is related to the contacting with suspected allergens. For decades, there has been no standard method for the treatment of RM, but with both conventional drug therapy and laser therapy having been attempted. Topical application of bleaching agents is mainly used as an auxiliary treatment modality. The laser treatment modality remains a hot spot, among which Q-switched Nd:YAG laser is well received for RM. Positive outcomes have been achieved by the combined treatment modalities attempted in recent years also achieve positive outcomes.